Literature DB >> 16896117

High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania.

Martha Lemnge1, Michael Alifrangis, Mwanaidi Y Kafuye, Method D Segeja, Samwel Gesase, Daniel Minja, Julius J Massaga, Anita M Rønn, Ib C Bygbjerg.   

Abstract

In May 2003, we studied amodiaquine (AQ) efficacy in children < 5 years of age with uncomplicated falciparum malaria in Magoda and Mpapayu (with insecticide treated nets [ITNs]) and Mgome (without ITNs) in Muheza, Tanzania. The trial involved 28 days of follow-up, and data were adjusted by polymerase chain reaction (PCR) genotyping of msp1 and msp2 genes. Additionally, Pfcrt codon 72-76 polymorphisms were studied by PCR and sequence-specific oligonucleotide probe (SSOP) ELISA. In 54 cases with complete follow-up, a significant difference in late treatment failure (LTF) rates was seen (60.7% in ITN versus 88.5% in non-ITN villages, P = 0.02) before PCR correction. However, after PCR correction, 23 cases (60.5%) were confirmed as reinfections, giving a true LTF rate of 21.4% (6/28) and 34.6% (9/26) in the above settings, respectively. Frequency of Pfcrt CVIET haplotype mutation pretreatment was high (97.0%); the remaining samples were CVMNK. We conclude that AQ alone is no longer effective in the study area.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896117

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

2.  Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT).

Authors:  Frank M Ringsted; Isolide S Massawe; Martha M Lemnge; Ib C Bygbjerg
Journal:  Malar J       Date:  2011-08-15       Impact factor: 2.979

3.  Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence.

Authors:  Deus S Ishengoma; Sudi Lwitiho; Rashid A Madebe; Nyagonde Nyagonde; Ola Persson; Lasse S Vestergaard; Ib C Bygbjerg; Martha M Lemnge; Michael Alifrangis
Journal:  Malar J       Date:  2011-01-12       Impact factor: 2.979

Review 4.  Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania.

Authors:  Alex Shayo; Joram Buza; Deus S Ishengoma
Journal:  Malar J       Date:  2015-03-29       Impact factor: 2.979

5.  Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania.

Authors:  Deus S Ishengoma; Bruno P Mmbando; Method D Segeja; Michael Alifrangis; Martha M Lemnge; Ib C Bygbjerg
Journal:  Malar J       Date:  2013-09-22       Impact factor: 2.979

6.  Sustained Effectiveness of a Fixed-Dose Combination of Artesunate and Amodiaquine in 480 Patients with Uncomplicated Plasmodium falciparum Malaria in Côte d'Ivoire.

Authors:  Serge Brice Assi; Abouo Franklin Nguessan; Yapo Thomas Aba; André Offianan Toure; Hervé Menan; Jean Claude Yavo; Koffi Moïse San; Emmanuel Bissagnéné; Stephan Duparc; Valérie Lameyre; Mea Antoine Tanoh
Journal:  Malar Res Treat       Date:  2017-12-07

7.  High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.

Authors:  Celine I Mandara; Filbert Francis; Mercy G Chiduo; Billy Ngasala; Renata Mandike; Sigsbert Mkude; Frank Chacky; Fabrizio Molteni; Ritha Njau; Ally Mohamed; Marian Warsame; Deus S Ishengoma
Journal:  Malar J       Date:  2019-03-25       Impact factor: 2.979

8.  Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria.

Authors:  Charles Mwanziva; Seif Shekalaghe; Arnold Ndaro; Bianca Mengerink; Simon Megiroo; Frank Mosha; Robert Sauerwein; Chris Drakeley; Roly Gosling; Teun Bousema
Journal:  Malar J       Date:  2008-11-05       Impact factor: 2.979

9.  Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.

Authors:  Asia Mohammed; Arnold Ndaro; Akili Kalinga; Alphaxard Manjurano; Jackline F Mosha; Dominick F Mosha; Marco van Zwetselaar; Jan B Koenderink; Frank W Mosha; Michael Alifrangis; Hugh Reyburn; Cally Roper; Reginald A Kavishe
Journal:  Malar J       Date:  2013-11-14       Impact factor: 2.979

10.  Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania.

Authors:  Alex Shayo; Celine I Mandara; Francis Shahada; Joram Buza; Martha M Lemnge; Deus S Ishengoma
Journal:  Malar J       Date:  2014-09-20       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.